|
Drug Therapy, Other
Citations 31-40 of 172 total displayed.
|
Past content
(since Feb 1998):
|
- Letters
Methodologic Aspects of Glaucoma Phamacogenomic Studies—Reply
- Catherine A. McCarty; James K. Burmester; Bickol N. Mukesh; Richard B. Patchett; Russell A. Wilke
Arch Ophthalmol 2009; 127: 706-a-707-a.
[Extract]
[Full text]
[PDF]
- Letters
Methodologic Aspects of Glaucoma Phamacogenomic Studies
- Christopher T. Leffler
Arch Ophthalmol 2009; 127: 706.
[Extract]
[Full text]
[PDF]
- Letters
Studies of Monocular Trials of Glaucoma Medications: Conflicting Results Explained by Varying Methods
- Christopher T. Leffler
Arch Ophthalmol 2009; 127: 707-708.
[Extract]
[Full text]
[PDF]
- Letters
Studies of Monocular Trials of Glaucoma Medications: Conflicting Results Explained by Varying Methods—Reply
- Omar Chaudhary; Ron A. Adelman; M. Bruce Shields
Arch Ophthalmol 2009; 127: 708-a.
[Extract]
[Full text]
[PDF]
- Clinical Trials
Retinal Effects of 6 Months of Daily Use of Tadalafil or Sildenafil
- William H. Cordell; Raj K. Maturi; Timothy M. Costigan; Michael F. Marmor; Richard G. Weleber; Stuart G. Coupland; Ronald P. Danis; John W. McGettigan Jr; Andrew N. Antoszyk; Suzanne Klise; Gregory D. Sides; for the ERG Testing During Chronic PDE5 Inhibitor Administration (ERG-PDE5i) Consortium
Arch Ophthalmol 2009; 127: 367-373.
[Abstract]
[Full text]
[PDF]
[ eFigure and eTables ]
- Clinical Trials
Pegaptanib Sodium for Macular Edema Secondary to Central Retinal Vein Occlusion
- John J. Wroblewski; John A. Wells III; Anthony P. Adamis; Ronald R. Buggage; Emmett T. Cunningham Jr; Mauro Goldbaum; David R. Guyer; Barrett Katz; Michael M. Altaweel; for the Pegaptanib in Central Retinal Vein Occlusion Study Group
Arch Ophthalmol 2009; 127: 374-380.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Topical Bevacizumab in the Treatment of Corneal Neovascularization: Results of a Prospective, Open-Label, Noncomparative Study
- Mohammad H. Dastjerdi; Khalid M. Al-Arfaj; Nambi Nallasamy; Pedram Hamrah; Ula V. Jurkunas; Roberto Pineda II; Deborah Pavan-Langston; Reza Dana
Arch Ophthalmol 2009; 127: 381-389.
[Abstract]
[Full text]
[PDF]
- Clinical Sciences
Management of Autoimmune Retinopathies With Immunosuppression
- Henry A. Ferreyra; Thiran Jayasundera; Naheed W. Khan; Shirley He; Ying Lu; John R. Heckenlively
Arch Ophthalmol 2009; 127: 390-397.
[Abstract]
[Full text]
[PDF]
- Clinical Sciences
Experimental and Clinical Evidence for Brimonidine as an Optic Nerve and Retinal Neuroprotective Agent: An Evidence-Based Review
- Meredith Saylor; Linda K. McLoon; Andrew R. Harrison; Michael S. Lee
Arch Ophthalmol 2009; 127: 402-406.
[Abstract]
[Full text]
[PDF]
- Clinical Sciences
In Vitro Effects of Histone Deacetylase Inhibitors and Mitomycin C on Tenon Capsule Fibroblasts and Conjunctival Melanoma Cells
- Thomas S. Cunneen; R. Max Conway; Michele C. Madigan
Arch Ophthalmol 2009; 127: 414-420.
[Abstract]
[Full text]
[PDF]
|
|
